To address the molecular and clinical correlates of ALCAM in tissue samples, we conducted in silico analyses in published datasets comparing ALCAM mRNA levels between normal and tumor tissues in several organs and found the largest increase in prostate and breast cancers (Figure S9). Here, ALCAM is linked to breast carcinoma.